Greenhaven Road reaffirms its Cellebrite thesis, citing AI tailwinds, legislative catalysts, and strong financials despite ...

Hip-hop and rap have been driving culture in the U.S. for almost four decades now, especially in America. So why are these ...

Pivoting to AI data centers and other high-growth markets seems like a strong move, but it begs the question of why the company waited so long to do so. At this point, Navitas Semiconductor is a ...

Greenhaven Road Capital's Q3 2025 letter analyzes a -9% return, citing no AI exposure and undervalued software holdings.

If you’re interesting in how you can make candle holders and flower pots from tin cans, how to use plastic bottles to make ...

How far off is Robert Walters plc from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company ...

Centessa Pharmaceuticals (CNTA) has been making waves recently as its stock experienced a swing over the past week. Investors are curious about the underlying performance that might be shaping the ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2025 and updated financial guidance for 2025.